Zhang Lu, Zhang Wei, Cai Huacong, Cao Xinxin, Chen Miao, Li Jian, Zhu Tienan, Duan Minghui, Wang Shujie, Han Bing, Zhou Daobin
Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Acta Haematol. 2017;137(4):240-246. doi: 10.1159/000473859. Epub 2017 Jun 7.
We reviewed patients with fever of unknown origin (FUO) and splenomegaly and assessed the diagnostic value of splenectomy and measured risk factors suggestive of an underlying lymphoma.
FUO patients (n = 83) who had splenomegaly and underwent splenectomy were enrolled into this retrospective single-center study. Clinical presentations were documented and risk factors suggestive of an underlying lymphoma were tested.
Seventy-four patients (89.2%) had a diagnosis of lymphoma or not after splenectomy and follow-up. Of those (55.4%) diagnosed with lymphoma, 29 had B-cell non-Hodgkin lymphoma and 12 had T-cell non-Hodgkin lymphoma. The remaining 33 (44.6%) had diseases other than lymphoma. Using multivariate logistic analysis, the following 3 independent risk factors were found to be related to a final diagnosis of lymphoma: age (continuous) (HR 1.086; 95% CI 1.033-1.141; p = 0.001), massively enlarged spleen (HR 7.797; 95% CI 1.267-47.959; p = 0.027), and enlarged intra-abdominal lymph nodes (HR 63.925; 95% CI 7.962-513.219; p < 0.001). The calibration of the model was satisfactory (p = 0.248 using the Hosmer-Lemeshow test), and the discrimination power was good (area under the receiver operating characteristic curve 0.925; 95% CI 0.863-0.987).
Splenectomy is an effective diagnostic procedure for patients with FUO and splenomegaly and lymphoma is a common cause. Older age, a massively enlarged spleen, and enlarged intra-abdominal lymph nodes are risk factors suggesting an underlying lymphoma, and surgery for high-risk patients should be considered.
我们回顾了不明原因发热(FUO)合并脾肿大的患者,并评估了脾切除术的诊断价值以及潜在淋巴瘤的测量风险因素。
将83例合并脾肿大并接受脾切除术的FUO患者纳入这项回顾性单中心研究。记录临床表现并检测提示潜在淋巴瘤的风险因素。
74例患者(89.2%)在脾切除术后及随访中被诊断为淋巴瘤或非淋巴瘤。在那些被诊断为淋巴瘤的患者中(55.4%),29例为B细胞非霍奇金淋巴瘤,12例为T细胞非霍奇金淋巴瘤。其余33例(44.6%)患有淋巴瘤以外的疾病。使用多因素逻辑分析,发现以下3个独立风险因素与最终淋巴瘤诊断相关:年龄(连续变量)(风险比1.086;95%置信区间1.033 - 1.141;p = 0.00)、脾脏重度肿大(风险比7.797;95%置信区间1.267 - 47.959;p = 0.027)和腹腔内淋巴结肿大(风险比63.925;95%置信区间7.962 - 513.219;p < 0.001)。模型校准良好(使用Hosmer-Lemeshow检验p = 0.248),鉴别能力良好(受试者操作特征曲线下面积0.925;95%置信区间%0.863 - 0.987)。
脾切除术是FUO合并脾肿大患者的有效诊断方法,淋巴瘤是常见病因。年龄较大、脾脏重度肿大和腹腔内淋巴结肿大是提示潜在淋巴瘤的风险因素,应考虑对高危患者进行手术。